Differential cell death in immortalized and non-immortalized cells at confluency

Oncogene

Volumn 12, Issue 1, 1996, Pages 201-206

  Brezden, C B ^a,c   Rauth, A M ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c NONE   (Canada)

Author keywords

Apoptosis; Confluency; Immortalized; Necrosis; Non immortalized; p53 independence

Indexed keywords

PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DEATH; CELL DENSITY; CELL IMMORTALIZATION; CELL TRANSFORMATION; CULTURE MEDIUM; EMBRYO; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NECROSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CHO CELLS; CRICETINAE; DNA DAMAGE; HELA CELLS; HUMANS; RATS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030042599     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bowen ID. (1993). Cell Biol. Interm., 17, 365-380.
2. Cumano A, Paige CJ, Iscove NN and Bradley G. (1992). Nature, 356, 612-615.
3. Demarcq C, Bunch TR, Creswell D and Eastman A. (1994). Cell Growth and Differ., 5, 983-993.
4. Donehower LA and Bradley A. (1993). Biochem, et Biophys. Acta., 1155, 181-205.
5. El-Deiry S, Kern SE, Pietenpol JA, Kinzler KW and Vogelstein B. (1992). Nature Genet., 1, 45-49.
6. Frisch SM and Francis H. (1994). J. Cell. Biol., 124, 619-626.
7. Gannoun-Zaki L, Pieri I, Badet J and Barritault D. (1994). Exp. Cell. Res., 213, 375-382.
8. Hollstein M, Sidransky D, Vogelstein B and Harris CC. (1991). Science, 253, 49-53.
9. Karnovsky MJ. (1964). J. Cell. Biol., 23, 217-232.
10. Kastan MB, Onyekwere O, Sidransky D, Volgelstein B and Craig RW. (1991). Cancer Res., 51, 6304-6311.
11. Ling V and Thompson LH. (1974). J. Cell. Physiol., 83, 103-116.
12. Lock RB, Galperina OV, Feldhoff RC and Rhodes LJ. (1994). Cancer Res., 54, 4933-4942.
13. Lowe SW, Ruley HE, Jacks T and Housman DE. (1993). Cell, 74, 957-967.
14. Mercer W, Avignolo C and Baserga R. (1984). Mol. Cell. Biol., 4, 276-281.
15. Meredith JE, Fazeli B and Schwartz MA. (1993). Mol. Biol. Cell, 4, 953-961.
16. Mirzayans R, Aubin RA, Blattner WA and Paterson MC. (1994). Br. J. Cancer, 68, 838-844.
17. Mymryk JS, Shire K and Bayley ST. (1994). Oncogene, 9, 1187-1193.
18. Peacock JW and Benchimol S. (1994). EMBO J, 13, 1084-1092.
19. Price TNC, Moorwood K, James MR, Burke JF and Mayne LV. (1994). Oncogene, 9, 2897-2904.
20. Smets LA. (1994). Anti-Cancer Drugs, 5, 3-9.
21. Tomei LD, Shapiro JP and Cope FO. (1993), Proc. Natl. Acad. Sci. USA, 90, 853-857.
22. Wyllie AH, Kerr JF and Currie AR. (1973). J Pathol., 111, 2552-2261.
23. Yonish-Rouach E, Grunwalk D, Wilder S, Kimchi A, May E, Lawrence J-J, May P and Oren M. (1993). Mol. Cell. Biol., 13, 1415-1423.
24. Yuan JY and Horvitz HR. (1990). Devel. Biol., 138, 33-41.